Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classifica tra le azioni #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Prezzo delle azioni
$0.1559364
Ultima sincronizzazione: 2026-09-18
Capitalizzazione di mercato
$195.17K
Variazione (1 giorno)
6.60%
Variazione (1 anno)
-30.91%
Paese
GB
Scambia Fusion Antibodies plc (FAB)

Categoria

Storico del prezzo dell'azione per Fusion Antibodies plc (FAB)
Prezzo di chiusura più alto: $0.15 il 2026-09-01

Prezzo di chiusura più basso: $2.40 il 2017-12-01
Storico del prezzo dell'azione di Fusion Antibodies plc dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -10.83%
2025 153.72%
2024 39.11%
2023 -88.99%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$509.53 32.99%
US
$991.92 34.63%
NL
$154.28 511.26%
US
$123.40 -5.68%
AU
$708.28 3.70%
CH